Earnings To Watch: Amgen (AMGN) Reports Q1 Results Tomorrow

robot
Abstract generation in progress

Biotech company Amgen (NASDAQ:AMGN) is set to report its Q1 earnings, with market expectations for a 4.3% year-on-year revenue growth. Amgen beat revenue expectations last quarter with an 8.6% increase, and analysts have recently become more bullish on its revenue estimates. Despite positive sentiment in the broader biotechnology segment, Amgen’s stock is down 2.9% over the last month.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin